tirzepatide in india (Mounjaro): India's New Dual-Action Treatment for Weight Management Indian pharma giant Cipla inks

Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained Weight Loss Company builds on nearly 10 years of GLP-1 experience, expanding its Sustainable Weight Loss solution to deliver medication-free and medication-assisted weight loss Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the companys approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic

FDA: Approval of Wegovy (semaglutide 2.4mg) for chronic weight management

The development of more potent and selective glutaminase inhibitors and effective delivery strategies remains an active area of research

For high-risk patients, semaglutide therapy can meaningfully lower the 10-year cardiovascular event probability